Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease

Clinical trial NCT04674735 · WITHDRAWN

Trial details

NCT number: NCT04674735
Sponsor: Apsen Farmaceutica S.A.
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Meniere Disease Vertigo Vertigo Vestibular

Start date: 2023-01-01
Primary completion: 2025-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.